9 Meters Biopharma Inc. (NMTR) Fundamentals

9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003 and others.
SHARE INFORMATION
Market Cap$ 57,858,678
Shares Outstanding259,107,380
Float255,952,637
Percent Float98.78%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.15
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions192
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months4,885,740
Institutional Holdings Percent32.1%
Institutional Sold Previous 3 Months31,393,941
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months1,330,054
Insider Holdings Percent2.2
Insider Sold Previous 3 Months-
Insider Shares Owned5,709,986
TRADING INFO
52 Week High$ 1.46
52 Week Low$ 0.20
52 Week High Change$ -81.99
21 Day Moving Average$ 0.2605
21 Day Extended Moving Average$ 0.252794
50 Day Moving Average$ 0.2552
50 Day Extended Moving Average$ 0.277378
200 Day Moving Average$ 0.518182
200 Day Extended Moving Average$ 0.51163
10 Day Average Volume752,788
20 Day Average Volume844,036
30 Day Average Volume1,179,409
50 Day Average Volume1,748,506
Alpha0.024773
Beta0.3775
Standard Deviation0.609912
R20.000975
7 Day Price Change$ -0.0217
7 Day Percent Change-8.86%
21 Day Price Change$ -0.0418
21 Day Percent Change-15.77%
30 Day Price Change$ -0.0536
30 Day Percent Change-19.36%
Month to Date Price Change$ -0.0418
Month to Date Percent Change-15.77%
Quarter to Date Price Change$ -0.0375
Quarter to Date Percent Change-14.38%
180 Day Price Change$ -0.36
180 Day Percent Change-61.72%
200 Day Price Change$ -0.327
200 Day Percent Change-59.42%
Year to Date Price Change$ -0.7554
Year to Date Percent Change-77.18%

9 Meters Biopharma Inc. (NMTR) Key Ratios

PROFITABILITY
EBIT Margin-766.7%
EBITDA Margin-759.1%
Pre-Tax Profit Margin-239.5%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.70
Total Debt To Equity0.00
Int Coverage-20,041.70
Current Ratio3.40
Leverage Ratio1.20
Quick Ratio3.20
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.40
Enterprise Value$ 30,591,195
Price to Sales0.00
Price to Free Cash-1.70
PE High Last 5 Years-1.50
Price To Book2.70
Price To Cash Flow0.00
PE Low Last 5 Years-1.60
Price to Tangible Book2.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-101.48
Return on Equity-122.61
Return on Capital-111.98

9 Meters Biopharma Inc. (NMTR) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMayer Hoffman McCann P.C.
CEOJohn Temperato
Emplyoees21
Last AuditUE
CIK0001551986
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address8480 Honeycutt Road
Suite 120
Raleigh, NC 27615
Websitehttps://www.9meters.com
Facsimile-
Telephone+1 919 275-1933
Emailjzimmons@innovatebiopharma.com


Your Recent History
NASDAQ
NMTR
9 Meters B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.